Prosecution Insights
Last updated: July 17, 2026
Application No. 18/628,035

METHOD FOR MANAGING BREAST MILK EXPRESSION

Non-Final OA §102§112
Filed
Apr 05, 2024
Examiner
HAYMAN, IMANI N
Art Unit
Tech Center
Assignee
Medela AG
OA Round
1 (Non-Final)
72%
Grant Probability
Favorable
1-2
OA Rounds
1y 0m
Est. Remaining
97%
With Interview

Examiner Intelligence

Grants 72% — above average
72%
Career Allowance Rate
521 granted / 727 resolved
+11.7% vs TC avg
Strong +25% interview lift
Without
With
+25.3%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
6 currently pending
Career history
731
Total Applications
across all art units

Statute-Specific Performance

§101
0.3%
-39.7% vs TC avg
§103
66.9%
+26.9% vs TC avg
§102
20.3%
-19.7% vs TC avg
§112
4.0%
-36.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 727 resolved cases

Office Action

§102 §112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 14-15 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claims 14-15 recite both an apparatus and a process of using the apparatus. When both an apparatus and a method are claimed in the same claim it is unclear whether infringement occurs when the apparatus is constructed or when the apparatus is used. Therefore the scope of the claim is indefinite. See MPEP 2173.05(p). Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1-2, 8-10, 14, 15 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by US 20170072118 to Makower. As to claim 1, Makower discloses a method for managing breast milk expression [0203] comprising: providing an expected milk yield over time (figures 30 and 32); expressing milk and measuring the expressed milk yield at a given time [0195; 0197]; comparing the measured milk yield at the given time with the expected milk yield at the given time [0199; 0206]; generating an alarm if the measured milk yield is lower than the expected yield (claim 7). As to claim 2, Makower discloses the method of claim 1, wherein the expected milk yield is provided with reference to a baby birth, and a measured milk yield is measured with reference to the baby birth [0199]. As to claim 8, Makower discloses the method of claim 1, wherein the method is implemented by a software executed by a processor of a smartphone or tablet or computer [0196-0197]. As to claim 9, Makower discloses the method of claim 1, wherein the method is implemented by a software executed by a processor of a controller of a breast pump [0196-0197]. As to claim 10, Makower discloses the method as defined in claim 8, wherein the software outputs information on the daily yield over time together with a path of expected yield over a time [0198]. As to claim 14, Makower discloses a software comprising instructions that, when executed by at least one programmable processor, cause the at least one programmable processor to implement the method of claim 1 [0197]. As to claim 15, Makower discloses a breast pump (figures 1a and 1b) comprising an aggregate (30) and a controller (52), the controller having at least one programmable processor (1604), wherein when the programmable processor executes the software according to claim 14 (structure capable of carrying out function). Allowable Subject Matter Claims 3-7, 11-13 objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to IMANI N HAYMAN whose telephone number is (571)270-5528. The examiner can normally be reached 5:30 AM - 3:30 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /IMANI N HAYMAN/Supervisory Patent Examiner, Art Unit 2841
Read full office action

Prosecution Timeline

Apr 05, 2024
Application Filed
Jun 03, 2026
Non-Final Rejection mailed — §102, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12623033
Safety Device for Shielding an Injection Needle of a Medical Container, and an Injection Device Including This Safety Device
3y 4m to grant Granted May 12, 2026
Patent 12599746
CUFFED AND NON-CUFFED DIALYSIS CATHETER SYSTEMS AND METHODS
3y 8m to grant Granted Apr 14, 2026
Patent 12599748
Catheter Tips for Rapidly Insertable Central Catheters and Methods Thereof
3y 4m to grant Granted Apr 14, 2026
Patent 12594403
Introducer Components, Assemblies, and Methods Thereof
3y 7m to grant Granted Apr 07, 2026
Patent 12578765
DISPLAY MODULE AND DISPLAY DEVICE
2y 11m to grant Granted Mar 17, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
72%
Grant Probability
97%
With Interview (+25.3%)
3y 3m (~1y 0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 727 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month